Allergy & Immunology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
Conditions: Pulmonary Aspergillosis; Chronic Pulmonary Aspergillosis; Allergic Bronchopulmonary Aspergillosis Interventions: Other: Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) Sponsors: Radboud University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Phase 3 Study of Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure
Conditions: Organ Grafts Interventions: Drug: TACROLIMUS Sponsors: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials

Immunological Mechanisms Underlying Mucosal IgE Responses
Conditions: Pathophysiology Interventions: Drug: Dupilumab Sponsors: University Hospital, Ghent; Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials

The Impact of an Evidence-based Myth-busting Information Intervention on Maternal Food Allergy Related Quality of Life, Anxiety and Self-efficacy
Conditions: Child Allergy; Food Allergy Interventions: Behavioral: " Myth busting " information leaflet Sponsors: Children ' s Health Ireland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
Conditions: Tuberculosis Interventions: Drug: TB preventive therapy (TPT) Sponsors: University of Washington; Human Sciences Research Council; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Over-the-Counter Antihistamines & Heat Stress
Conditions: Heat Illness; Allergic Rhinitis; Heat Injury; Sudomotor Sympathetic Dysfunction Interventions: Drug: 50 mg Diphenhydramine; Drug: 10 mg Loratadine; Drug: 5 mg Desloratadine; Other: Placebo (Sugar Pill) Sponsors: Lakehead University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
Conditions: Seasonal Allergic Conjunctivitis Interventions: Drug: Epinastine Hcl Oph Soln+Simulating Azelastine Hcl Oph Soln; Drug: Azelastine Hcl Oph Sol+Simulating Epinastine Hcl Oph Soln Sponsors: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials

Papuan Indigenous Model of Male Circumcision
Conditions: HIV Infections Interventions: Procedure: Medical male circumcision using standard surgical technique. Sponsors: University of Illinois at Chicago; National Institute of Allergy and Infectious Diseases (NIAID); Atma Jaya Catholic University of Indonesia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials

Angioedema Biomarker Research Study
Conditions: Angioedema; Angioedemas, Hereditary; Urticaria; Mastocytosis; ACE Inhibitor-Induced Angioedema; C1 Inhibitor Deficiency; Systemic Mastocytoses; Indolent Systemic Mastocytosis Interventions: Diagnostic Test: Venipuncture Sponsors: Foundation For Rare Disease Research; Institute for Asthma& Allergy; Virant Diagnostics, Inc.; MedBio Reference Laboratories, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Evaluation of Pharmacist-led Medication Reconciliation Service Benefits in Hospitalised Medical Patients
Conditions: Medication Reconciliation Interventions: Procedure: Pharmacist-led Medication Reconciliation Sponsors: The University Clinic of Pulmonary and Allergic Diseases Golnik; University of Ljubljana Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
Conditions: Tuberculosis, Pulmonary Interventions: Biological: ID93 + GLA-SE vaccine; Biological: Placebo vaccine Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
Conditions: HIV-1-infection Interventions: Drug: 3BNC117-LS; Drug: 10-1074-LS; Drug: Placebo for 3BNC117-LS; Drug: Placebo for 10-1074-LS Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA
Conditions: Mild to Moderate Cows ' Milk Protein Allergy Interventions: Other: extensive hydrolyzed protein formula Sponsors: Danone Specialized Nutrition Indonesia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Conditions: Human Immunodeficiency Virus Interventions: Biological: Ad26.Mos4.HIV [Arm 1]; Biological: Ad26.Mos4.HIV [Arm 2]; Biological: CH505 TF chTrimer+ALFQ [Arm 1]; Biological: CH505 TF chTrimer+ALFQ [Arm 2]; Biological: ALFQ [Arm 1]; Biological: ALFQ [Arm 2] Sponsors: U.S. Army Medical Research and Development Command; Janssen Vaccines& Prevention B.V.; Henry M. Jackson Foundation for the Advancement of Military Medicine; Duke University; Walter Reed Army Institute of Research (WRAIR); National Institute of Allergy and Infectious Diseases (NIAID); Makerere University Walter Reed Project Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis
Conditions: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone furoate as a nasal spray Sponsors: Zheng Liu ENT; Zhejiang Xianju Pharma Tech. Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials